Tech Company Financing Transactions
Boston Pharmaceuticals Funding Round
Boston Pharmaceuticals secured a $600 million funding round on 11/20/2015. Investors included Gurnet Point Capital and private investors.
Transaction Overview
Company Name
Announced On
11/20/2015
Transaction Type
Venture Equity
Amount
$600,000,000
Round
Undisclosed
Investors
Gurnet Point Capital (Christopher Viehbacher)
private investors (Robert Armstrong)
Proceeds Purpose
Boston Pharmaceuticals is a fully-integrated drug development company that will offer an innovative alternative model for drug development and commercialization.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
This is a new way to develop and to bring to market innovative medicines. We believe that the combination of our dedicated capital pool and extensive industry expertise will give Boston Pharmaceuticals a significant competitive advantage in this space.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Armstong
Browse more venture capital transactions:
Prev: 11/20/2015: Tubi TV venture capital transaction
Next: 11/20/2015: Le Tote venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs